Citadel Advisors - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 70 filers reported holding KEMPHARM INC in Q3 2022. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of KEMPHARM INC
ValueSharesWeighting
Q3 2023$1,279,566
+56.2%
265,470
+65.3%
0.00%
Q2 2023$819,269
-34.5%
160,641
-29.4%
0.00%
Q1 2023$1,251,173
-36.3%
227,486
-46.9%
0.00%
Q4 2022$1,964,795
-36.2%
428,060
-13.3%
0.00%
Q3 2022$3,082,000
+38.6%
493,900
-0.9%
0.00%
Q2 2022$2,223,000
-24.7%
498,500
-15.0%
0.00%
Q1 2022$2,951,000
-50.1%
586,600
-13.7%
0.00%
-100.0%
Q4 2021$5,919,000
+80.0%
679,613
+92.8%
0.00%
Q3 2021$3,289,000
+9.5%
352,578
+50.4%
0.00%
Q2 2021$3,004,000
-43.3%
234,366
-59.3%
0.00%
-100.0%
Q1 2021$5,300,000576,0710.00%
Other shareholders
KEMPHARM INC shareholders Q3 2022
NameSharesValueWeighting ↓
Retirement Planning Co of New England, Inc. 327,583$1,801,7071.09%
Mystic Asset Management, Inc. 177,533$976,4320.54%
GREAT POINT PARTNERS LLC 347,824$1,913,0320.38%
Kovack Advisors, Inc. 122,822$675,5210.09%
City State Bank 14,224$780.04%
Arete Wealth Advisors, LLC 82,290$4530.04%
VisionPoint Advisory Group, LLC 10,217$49,8590.02%
Laurion Capital Management LP 571,200$3,141,6000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 95,143$523,2870.01%
Janney Montgomery Scott LLC 528,755$2,9080.01%
View complete list of KEMPHARM INC shareholders